40_CFR_01.02

Intragen log record 40:CFR-01.Dr. Leonard Kendall, - Ingen Bio - Senior Director of Applied Biotechnology.

> I have begun longitudinal chemotherapy research on a new experimental recombinant protein: Intragen.

Recent Posts

> Cytotoxicity and its effect on lymphocytes is of utmost importance. I must find a way to balance the protein's effects. If I am successful, it will mean no more cancer, no more HIV virus, no more Eb

40_CFR_01.05

CLASSIFIED: INGEN BIO ARCHIVE - EYES ONLY PERSONNEL